Napier Park Global Capital (Us) LP Biogen Inc. Call Options Transaction History

Napier Park Global Capital (Us) LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $8.41 Million - $11.1 Million	-32,500 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $1.65 Million - $2.28 Million	-7,500 Reduced 18.75%	32,500 $118,000
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $8.67 Million - $13.6 Million	40,000 New	40,000 $42,000

1,018

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Napier Park Global Capital (Us) LP, based on Form 13F filings with the SEC.

Stay updated on Napier Park Global Capital (Us) LP with notifications on news.